Skip to content
COMPANY
PRODUCTS
R & D
Product Candidates Overview
Pipeline
Orphan Drug Designations
PARTNERING
INVESTOR RELATIONS
Press Releases
Events & Presentations
Stock Information
SEC Filings
XBRL Filings
Stockholder Meeting
Corporate Governance
Email Alerts
Investor Contact
BLOG
CONTACT
Press Releases
Hemispherx Scientists Report New Method To Evaluate Chronic Fatigue Syndrome
HEMISPHERX BIOPHARMA SELECTED BY MSN MONEY CENTRAL'S STOCKSCOUTER AS ONE OF HIGHEST RATED SMALL-CAP BIOTECHS
HEMISPHERX BIOPHARMA SPONSORS GLOBAL AIDS FUNDRAISER AT UNITED NATIONS
HEMISPHERX BIOPHARMA INITIATES TREATMENT IN TWO NEW CLINICAL STUDIES OF MULTI-DRUG RESISTANT HIV-INFECTION IN U.S.A.--Culminates 15 Year Period of Discoveries-
Hemispherx Biopharma, LabCorp® combine forces for Nationwide testing in HIV Immunotherapy Clinical Trials
78
79
80
81
82
83
<<
<
>
>>
Privacy